AA
AMRI

AQR Arbitrage’s Albany Molecular Research Inc AMRI Stock Holding History

AQR Arbitrage’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-862,379
Closed -$18.7M – 370
2017
Q2 		$18.7M Buy
+862,379
New +$15.7M 0.2% 122

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

AQR Arbitrage's AMRI Position: Q3 2017 in Review

AQR Arbitrage sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 862,379 shares — an estimated $18.7M sold.

AQR Arbitrage first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $18.7M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • AQR Arbitrage reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • AQR Arbitrage sold 862,379 Albany Molecular Research Inc shares in Q3 2017, an estimated $18.7M.
  • AQR Arbitrage first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • AQR Arbitrage's Albany Molecular Research Inc position peaked at $18.7M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on AQR Arbitrage's 13F filing for Q3 2017, filed 14 Nov 2017.